AbCellera has announced two key additions to its leadership team – Andrew Booth, formerly of STEMCELL Technologies, and Tryn Stimart, formerly of Gibbons P.C.
They will be joining the privately-held therapeutic antibody discovery company as chief financial officer and general counsel, respectively.
Booth has many years of experience in corporate growth and finance, both at STEMCELL and GE Healthcare and Stimart is a veteran in the field of biotech/pharma legal counsel – previously working with highly esteemed law offices and pharma clients like Gilead and Takeda on high-profile business and IP disputes.
